文献速递临床试验与 GCP基础与转化研究

DASH饮食与同期训练对缺血性心脏病患者心脏代谢危险因素及肠道菌群影响:随机对照试验研究方案

The impact of DASH diet and concurrent training on cardiometabolic risk factors and gut microbiota in individuals with ischemic heart disease: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2025-12-08

本研究为2×2析因随机对照临床试验,计划招募48名40-70岁缺血性心脏病男性,随机分为DASH饮食组、同期训练组、DASH饮食联合同期训练组及常规照护对照组,干预8周,评估肠道菌群、氧化型低密度脂蛋白及心脏代谢危险因素等指标。

要点

  • 拟纳入48名40-70岁缺血性心脏病男性,随机分为DASH饮食、同期训练、联合干预及对照组,干预8周。
  • 主要检测肠道菌群(包括厚壁菌门、拟杆菌门、双歧杆菌属等)及心脏代谢危险因素。
  • 作者称这是首个在缺血性心脏病男性中测试短期同期训练联合DASH饮食对肠道菌群多样性及心脏代谢危险因素影响的随机对照试验。

核心结论

  • 作者称本研究是首个在缺血性心脏病男性中测试短期同期训练联合DASH饮食对肠道菌群多样性及多项心脏代谢危险因素影响的随机对照试验。

研究设计与样本

  • 平行随机对照2×2析因临床试验,计划招募48名40-70岁缺血性心脏病男性,随机分为DASH饮食组、同期训练组、DASH饮食联合同期训练组及常规照护对照组,干预8周。
  • 在基线和研究结束时采集粪便样本和血清,检测肠道菌群(厚壁菌门、拟杆菌门、双歧杆菌属、梭菌属、普拉梭菌、Akkermansia muciniphila)及心脏代谢危险因素。
  • 同时评估人体测量指标、血压、生活质量、6分钟步行试验和贝克抑郁量表(BDI)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ischemic heart disease (IHD) has a substantial burden on individuals and health system infrastructure worldwide. Meanwhile, mounting evidence has declared remarkable contrasts in gut microbiota between individuals with IHD and healthy counterparts. The Dietary Approaches to Stop Hypertension (DASH) might be one of the most reliable strategies to manage cardiometabolic risk factors. Nonetheless, no experiment has tested the impact of a DASH diet and exercise on gut microbiota composition in IHD individuals. Hence, we aim to explore the effects of a DASH diet and concurrent exercise on gut microbiota, oxidized LDL, and cardiometabolic risk factors among men. METHODS: In total, 48 men aged 40-70 years with IHD will be recruited in this parallel randomized, controlled, 2 × 2 factorial clinical trial. These patients will be randomly assigned to the following four intervention groups: DASH diet (D), concurrent exercise (E), concurrent DASH diet and exercise (DE), and control (usual care) (C) for 8 weeks. At baseline and the end of the study, stool samples and serum levels will be gathered to detect gut microbiota (Firmicutes, Bacteroidetes, Bifidobacteria, clostridium, Faecalibacterium prausnitzi, Bacteroidetes, and Akkermansia muciniphila) and cardiometabolic risk factors, as well as anthropometric measures, blood pressure, quality of life, 6-min walking test, and Beck Depression Inventory (BDI). DISCUSSION: Based on our information, the present study is the primary randomized controlled trial testing the impacts of short-term concurrent training and DASH diet on intestinal bacteria diversity and several cardiometabolic risk factors in men with IHD. TRIAL REGISTRATION: Iranian Registry of Clinical Trials (www.irct.ir, IRCT20181205041859N1). Registered on 29 September 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pourfard NR, Dehkordi KJ, Sadeghi M, et al. The impact of DASH diet and concurrent training on cardiometabolic risk factors and gut microbiota in individuals with ischemic heart disease: a study protocol for a randomized controlled trial. Trials. 2025. PMID: 41361831. doi:10.1186/s13063-025-09130-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。